These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sudden death due to cardiac arrhythmias. Huikuri HV; Castellanos A; Myerburg RJ N Engl J Med; 2001 Nov; 345(20):1473-82. PubMed ID: 11794197 [No Abstract] [Full Text] [Related]
3. [Clinical therapy for arrhythmias and EBM]. Otsuka T; Yamashita T Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):234-9. PubMed ID: 16536072 [No Abstract] [Full Text] [Related]
4. Amiodarone for the Prevention of Sudden Cardiac Death. Saguil A Am Fam Physician; 2016 Nov; 94(9):692-693. PubMed ID: 27929253 [No Abstract] [Full Text] [Related]
5. Combination ICD and drug treatments-best options. Dorian P Resuscitation; 2000 Aug; 45(3):S3-6. PubMed ID: 10959027 [No Abstract] [Full Text] [Related]
6. Sudden cardiac death prevention: antiarrhythmic drugs and the implantable cardioverter-defibrillator. Domanski MJ J Interv Cardiol; 1995 Feb; 8(1):9-15. PubMed ID: 10155222 [No Abstract] [Full Text] [Related]
7. Sudden cardiac death: prevention and treatment. Kwok KM; Lee KL; Lau CP; Tse HF Hong Kong Med J; 2003 Oct; 9(5):357-62. PubMed ID: 14530531 [TBL] [Abstract][Full Text] [Related]
8. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy. Adabag AS; Maron BJ Ann Noninvasive Electrocardiol; 2007 Apr; 12(2):171-80. PubMed ID: 17593187 [No Abstract] [Full Text] [Related]
9. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated]. Alboni P Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849 [TBL] [Abstract][Full Text] [Related]
10. [Arrhythmias in cardiomyopathies]. Kaneko Y; Kurabayashi M Nihon Rinsho; 2002 Jul; 60(7):1434-9. PubMed ID: 12136626 [TBL] [Abstract][Full Text] [Related]
11. Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy. Droogan C; Patel C; Yan GX; Kowey PR Heart Fail Clin; 2011 Apr; 7(2):195-205, viii. PubMed ID: 21439498 [TBL] [Abstract][Full Text] [Related]
13. [Drug therapy of ventricular arrhythmias - a contemporary perspective]. Grönefeld GC; Hohnloser SH Dtsch Med Wochenschr; 2002 Oct; 127(43):2280-4. PubMed ID: 12397544 [No Abstract] [Full Text] [Related]
14. [Fundamental principle in therapy for arrhythmia]. Atarashi H Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):228-33. PubMed ID: 16536071 [No Abstract] [Full Text] [Related]
15. [Effect of drug therapy on frequency of adequate discharges of implanted cardioverter defibrillator]. Tiroke A; Ganeeva ON Kardiologiia; 2003; 43(6):54-8. PubMed ID: 12891312 [TBL] [Abstract][Full Text] [Related]
16. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]